-
Targets to Therapies: Mitochondrial Target Validation
… Objective: The Targets to Therapies Program seeks to build a robust evidence base for mitochondrial targets with high potential relevance to Parkinson’s disease. …
-
New Tool May Help Researchers Predict Cognitive Decline with Parkinson's Disease
June 23, 2017
… A new tool from researchers at Harvard Medical School may allow investigators to predict cognitive decline in people with Parkinson's disease … trials and test new therapies. The tool uses an algorithm combining varied personal details -- age at onset, baseline …
-
PPMI Dispatch: Predicting Cognitive Changes and Lipid Levels with a LRRK2 Mutation
February 27, 2023
… Markers Initiative (PPMI), continues its expansion to enroll new participants across the globe. To date, more … using PPMI data and samples. Genetics and Weight Loss May Predict Cognitive Changes Some people with Parkinson’s … could help select people with these factors for studies testing therapies to prevent or ease cognitive impairment. …
-
Global Charities Join Forces to Drive Forward New Drug for Parkinson’s
November 23, 2020
… L eading charities have provided biopharma company Neurolixis joint funding to test a new drug to reduce dyskinesia in people with … of Team Fox members around the world. For more information, visit https://michaeljfox.org . About Neurolixis Neurolixis …
-
New York Yankee Legends to Support Team Fox on Father’s Day
May 19, 2015
… and stay for the post-game Father’s Day BBQ feast! To purchase tickets: Call 570-969-2255 or visit the online …
-
Development of Functional Imaging for CB-1 and 5-HT1a in PD Participants with Dyskinesia
… Objective/Rationale: The goal of this proposal is to develop two imaging tests, [18F]MK-9470 and [18F]MPPF, to assess the function of … activity). The data in PD subjects with dyskinesia will be compared with early PD subjects and healthy subjects to …